The evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis

被引:6
|
作者
Li, Ze-Shi [1 ,2 ]
Wang, Kuo [3 ]
Pan, Tuo [1 ,2 ]
Sun, Yan-Hua [4 ]
Liu, Chang [5 ]
Cheng, Yong-Qing [5 ]
Zhang, He [1 ,2 ]
Zhang, Hai-Tao [1 ,2 ]
Wang, Dong-Jin [1 ,2 ,3 ,5 ]
Chen, Zu-Jun [6 ]
机构
[1] Peking Union Med Coll, Nanjing Drum Tower Hosp, Dept Cardiothorac Surg, Nanjing 210008, Jiangsu, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Nanjing 210008, Jiangsu, Peoples R China
[3] XuZhou Med Univ, Nanjing Drum Tower Hosp, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China
[4] Nanjing Univ, Med Sch, Affiliated Hosp, Dept Anesthesia,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China
[5] Nanjing Univ, Med Sch, Dept Cardiothorac Surg, Nanjing Drum Tower Hosp,Affiliated Hosp, Nanjing, Jiangsu, Peoples R China
[6] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Dept Intens Care Unite, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Levosimendan; Ventricular septal rupture; Cardiac surgery; Coronary artery bypass grafting; Mortality; Postoperative complication; INTRAAORTIC BALLOON PUMP; RISK-FACTORS; PREOPERATIVE LEVOSIMENDAN; PROPHYLACTIC LEVOSIMENDAN; MECHANICAL COMPLICATIONS; CARDIOPULMONARY BYPASS; CARDIOGENIC-SHOCK; OUTPUT SYNDROME; MORTALITY; SUPPORT;
D O I
10.1186/s12871-022-01663-z
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Study objective The purpose of the present study was to evaluate the efficacy of levosimendan in patients with acute myocardial infarction related ventricular septal rupture (AMI-VSR) underwent cardiac surgery. Design Prospective observational cohort study with propensity score analysis. Patients There were 261 patients with AMI-VSR in our study. After 1:1 propensity matching, 106 patients (53 levosimendan and 53 control) were selected in the matched cohort. Interventions None. Measurements Patients who received levosimendan were assigned to the levosimendan group (n = 164). The patients who were not received were levosimendan assigned to the control group (n = 97). The levosimendan was initiated immediately after cardiopulmonary bypass. Then, it has been maintained during the postoperative 3 days. The poor outcomes were identified as follows: death and postoperative complications (postoperative stroke, low cardiac output syndromeneeded mechanical circulatory support after surgery, acute kidney injury (>= stage III), postoperative infection or septic shock, new developed atrial fibrillation or ventricular arrhythmias). Main results Before matching, the control group had more length of ICU stay (6.69 +/- 3.90 d vs. 5.20 +/- 2.24 d, p < 0.001) and longer mechanical ventilation time (23 h, IQR: 16-53 h vs. 16 h, IQR: 11-23 h, p < 0.001). Other postoperative outcomes have not shown significant differences between two groups. After matching, no significant difference was found between both groups for all postoperative outcomes. The Kaplan-Meier survivul estimate and log-rank test showed that the 90-day survival had no significant differences between two groups before and after matching. Conclusion Our study found that a low-dose infusion of levosimendan in AMI-VSR patients underwent surgical repair did not associated with positively affect to postoperative outcomes.
引用
收藏
页数:10
相关论文
共 35 条
  • [31] Left Atrial Appendage Closure Significantly Reduces the Incidence of Post-operative Cerebrovascular Accidents in Patients Undergoing Cardiac Surgery: Analysis Based on a Single Center Prospective Observational Study
    Iwamura, Tai
    Kato, Tomoko S.
    Nakamura, Hiroshi
    Yokoyama, Yasutaka
    Kuwaki, Kenji
    Morita, Terumasa
    Inaba, Hirotaka
    Yamamoto, Taira
    Amano, Atsushi
    CIRCULATION, 2014, 130
  • [32] What is the best pre-operative risk stratification tool for major adverse cardiac events following elective vascular surgery? A prospective observational cohort study evaluating pre-operative myocardial ischaemia monitoring and biomarker analysis
    Biccard, B. M.
    Naidoo, P.
    de Vasconcellos, K.
    ANAESTHESIA, 2012, 67 (04) : 389 - 395
  • [33] Perioperative Factor Concentrate Use is Associated With More Beneficial Outcomes and Reduced Complication Rates Compared With a Pure Blood Product-Based Strategy in Patients Undergoing Elective Cardiac Surgery: A Propensity Score-Matched Cohort Study
    Nemeth, Endre
    Varga, Tamas
    Soltesz, Adam
    Racz, Kristof
    Csikos, Gergely
    Berzsenyi, Viktor
    Tamaska, Eszter
    Lang, Zsolt
    Molnar, Gabriella
    Benke, Kalman
    Eory, Ajandek
    Merkely, Bela
    Gal, Janos
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (01) : 138 - 146
  • [34] Risk of contrast-induced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data
    Chatterjee, Saurav
    Kundu, Amartya
    Mukherjee, Debabrata
    Sardar, Partha
    Mehran, Roxana
    Bashir, Riyaz
    Giri, Jay
    Abbott, Jinnette D.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017, 90 (02) : 205 - 212
  • [35] Prediction of 1-Year Clinical Outcomes Using the SYNTAX Score in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention A Substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) Trials
    Garg, Scot
    Sarno, Giovanna
    Serruys, Patrick W.
    Rodriguez, Alfredo E.
    Bolognese, Leonardo
    Anselmi, Maurizio
    De Cesare, Nicoletta
    Colangelo, Salvatore
    Moreno, Raul
    Gambetti, Stefania
    Monti, Monia
    Bristot, Laura
    Bressers, Marco
    Garcia-Garcia, Hector M.
    Parrinello, Giovanni
    Campo, Gianluca
    Valgimigli, Marco
    JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (01) : 66 - 75